These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 22019005
21. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study). Tikkanen MJ, Holme I, Cater NB, Szarek M, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, Incremental DEcrease through Aggressive Lipid Lowering Investigators. Am J Cardiol; 2009 Mar 01; 103(5):577-82. PubMed ID: 19231315 [Abstract] [Full Text] [Related]
25. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study). Foody JM, Brown WV, Zieve F, Adewale AJ, Flaim D, Lowe RS, Jones-Burton C, Tershakovec AM. Am J Cardiol; 2010 Nov 01; 106(9):1255-63. PubMed ID: 21029821 [Abstract] [Full Text] [Related]
26. Cardiovascular and economic outcomes after initiation of atorvastatin versus simvastatin in an employed population stratified by cardiovascular risk. Simpson RJ, Signorovitch J, Ramakrishnan K, Ivanova J, Birnbaum H, Kuznik A. Am J Ther; 2011 Nov 01; 18(6):436-48. PubMed ID: 20802306 [Abstract] [Full Text] [Related]
27. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model. Shinozaki T, Matsuyama Y, Iimuro S, Umegaki H, Sakurai T, Araki A, Ohashi Y, Ito H, Japanese Elderly Diabetes Intervention Trial Research Group. Geriatr Gerontol Int; 2012 Apr 01; 12 Suppl 1():88-102. PubMed ID: 22435944 [Abstract] [Full Text] [Related]
33. Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population. Simpson RJ, Signorovitch J, Birnbaum H, Ivanova J, Connolly C, Kidolezi Y, Kuznik A. Mayo Clin Proc; 2009 Dec 01; 84(12):1065-72. PubMed ID: 19955243 [Abstract] [Full Text] [Related]
36. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes. Waters DD, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJ, Messig M, Breazna A, Pedersen TR. J Am Coll Cardiol; 2013 Jan 15; 61(2):148-52. PubMed ID: 23219296 [Abstract] [Full Text] [Related]